Seropositive rheumatoid arthritis affecting the heart (carditis, endocarditis, myocarditis, or pericarditis) in a patient whose joint disease involves multiple anatomical sites simultaneously.
Verified May 8, 2026 · 5 sources ↓
- Status
- Billable
- Chapter
- 13
- Related CPT
- 10
- Region
- Multi-region
Documentation tips
What should appear in the chart to support M05.39.
Source · Editorial brief grounded in 5 cited references ↓
- Explicitly document rheumatoid factor positivity (seropositivity) — M05 codes require it; seronegative patients belong in M06.
- Name the specific cardiac manifestation: rheumatoid carditis, endocarditis, myocarditis, or pericarditis — the term 'cardiac involvement' alone is insufficient for audit defense.
- List every joint region affected to justify 'multiple sites'; a joint-by-joint problem list or examination note satisfies this requirement.
- Record echocardiogram, EKG, or cardiac imaging findings that corroborate the rheumatoid heart disease diagnosis.
- Note the ordering or consulting rheumatologist's confirmation of seropositive RA with cardiac manifestations to support the M05.39 selection over M06 alternatives.
Related CPT procedures
Procedure codes commonly billed with M05.39. Linking the right diagnosis to the right procedure is what establishes medical necessity.
Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis
Common coding pitfalls
The recurring mistakes coders make with M05.39 and adjacent codes.
Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓
- Confusing rheumatoid heart disease (M05.3x) with rheumatic heart disease (I01.x–I09.x) — these are distinct conditions with separate code families; never substitute one for the other.
- Dropping to an unspecified or single-site M05.3 subcode when the chart clearly documents multiple joint involvement — that under-codes complexity and may trigger downcoding on audit.
- Applying M05.39 to a patient with juvenile RA and cardiac involvement — M08.- governs juvenile RA regardless of rheumatoid factor status; M05 is Excludes1 for M08.
- Using M05.39 when only the spine is affected — spinal RA belongs exclusively to M45.- and is Excludes1 under M05.
- Omitting a cardiac-specific secondary code when the payer or care setting requires granular cardiac diagnosis detail alongside the M05.39 claim.
Clinical context
Source · Editorial summary grounded in 5 cited references ↓
M05.39 applies when a patient with rheumatoid-factor-positive (seropositive) rheumatoid arthritis has documented cardiac involvement — specifically rheumatoid carditis, endocarditis, myocarditis, or pericarditis — and the arthritis itself spans multiple joint sites. The 'multiple sites' qualifier is the key differentiator from the single-laterality codes in the M05.3x series (e.g., M05.31 for shoulder, M05.37 for ankle/foot). Use M05.39 only when the clinical record explicitly documents polyarticular disease alongside the cardiac manifestation.
This code sits within the M05 category, which is restricted to seropositive RA. If rheumatoid factor status is not documented or is negative, fall to M06.39 (other rheumatoid arthritis of multiple sites with cardiac involvement) or the appropriate seronegative equivalent. M05 carries a hard Excludes1 against rheumatic fever (I00) and juvenile RA (M08.-) — never use M05.39 when either of those is the driving diagnosis. Rheumatoid arthritis of the spine belongs to M45.- and is also excluded from M05.
In an orthopedic setting, M05.39 surfaces most often as a comorbidity code during preoperative risk stratification for joint replacement or during management of advanced polyarticular RA. Cardiac involvement elevates surgical risk and may require cardiology clearance; accurate coding of this comorbidity affects case-mix complexity, risk adjustment, and payer authorization decisions.
Sibling codes
Other billable codes under M05.3 (laterality / anatomic variants).
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 5 cited references ↓
01What cardiac conditions are included under M05.39?
02How many joints must be involved to use 'multiple sites'?
03Can M05.39 be used for a patient with seronegative RA and heart involvement?
04Is it correct to code M05.39 alongside a separate cardiac diagnosis code?
05Does M05.39 apply to spine-dominant rheumatoid arthritis with cardiac involvement?
06When would an orthopedic practice code M05.39 rather than a rheumatology practice?
07Is M05.39 valid for encounters on or after October 1, 2025?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CDC ICD-10-CM Tabular List 2026 (effective October 1, 2025)
- 02icd10data.comhttps://www.icd10data.com/ICD10CM/Codes/M00-M99/M05-M14/M05-/M05.39
- 03aapc.comhttps://www.aapc.com/codes/icd-10-codes/M05.39
- 04rhinomds.comhttps://rhinomds.com/m05-icd-10-codes-for-rheumatoid-arthritis-2026-a-billing-coding-guide/
- 05bellmedex.comhttps://bellmedex.com/icd-10-cm-m05-codes-for-rheumatoid-arthritis/
Mira AI Scribe
Mira's AI scribe captures rheumatoid factor status, the named cardiac manifestation (carditis, endocarditis, myocarditis, or pericarditis), and each affected joint region from the encounter note. That data locks in M05.39 versus a seronegative M06 code and prevents a single-site downcode — both of which trigger claim scrutiny and potential reimbursement reduction.
See how Mira captures M05.39 documentation